Allograft-specific considerations in transplant dermatology

Skin Disease in Organ Transplantation

Volumn , Issue , 2008, Pages 39-45

  Hirose, Ryutaro ^a   Otley, Clark C ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Mayo Clinic College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80054743692     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511547379.010     Document Type: Chapter

References (20)

1. The Organ Procurement and Transplantation Network. www.OPTN.org. Accessed 11/29/06.
2. Scientific Registry of Organ Transplant Recipients. www.ustransplant.org. Accessed 11/29/06.
3. United Network for Organ Sharing. www.UNOS.org. Accessed 11/29/06.
4. Moosa MR, Gralla J. Skin cancer in renal allograft recipients – experience in different ethnic groups residing in the same geographic region. Clin Transplant 2005;19:735–741.
5. Lindelof B, Sigurgeirsson B, Gabel H, Stern RS. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 2000;143:513–19.
6. Otley CC, Cherikh WS, Salasche SJ, McBride MA, Christenson LJ, Kauffman HM. Skin cancer in organ transplant recipients: effect of pretransplant end-organ disease. J Am Acad Dermatol 2005;53: 783–90.
7. Euvrard S, Kanitakis J, Decullier E, et al. Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma. Transplantation 2006;81:1093–100.
8. Gaston RS. Current and evolving immunosuppressive regimens in kidney transplantation. Am J Kid Dis 2006;47(Suppl 2):S3–21.
9. Fortina AB, Piaserico S, Caforio A, et al. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients. Arch Dermatol 2004; 140:1079–1085.
10. Agueroo J, Almenar L, Martinez-Dolz L, et al. Variation in the frequency and type of infections in heart transplantation according to the immunosuppression regimen. Transplant Proc 2006;38: 2558–9.
11. Euvrard S, Ulrich C, Lefrancois N. Immunosuppressants and skin cancer in transplant patients: focus on rapamycin. Dermatol Surg 2004;30:628–33.
12. Otley CC, Berg D, Ulrich C, et al. Reduction of immunosuppression for transplant-associated skin cancer: expert consensus survey. Br J Dermatol 2006;154:395–400.
13. Said A, Lucey MR. Liver transplantation: an update. Curr Opin Gas-troenterol 2006;22:272–8.
14. Jensen P, Hansen S, Moller B. et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999;40:177–186.
15. Gjersvik P, Hansen S, Moller B et al. Are heart transplant recipients more likely to develop skin cancer than kidney transplant recipients?. Transpl Int 2000;13(Suppl. 1)5380–1.
16. BelloniFortina A, Caforio AL, Piaserico S et al. Skin cancer in heart transplant recipients: Frequency and risk factor analysis. J Heart Lung Transplant 2000;19:249–255.
17. Naldi L, Fortina AB, Lovati S et al. Risk of nonmelanoma skin cancer in Italian organ transplant recipients. A registry-based study. Transplantation 2000;70:1479–84.
18. Meyer NJ, Bhorade SM. Evolving immunosuppressive regimens for lung transplant recipients. Semin Respir Crit Care Med 2006;27: 470–9.
19. Eisen H, Ross H. Optimizing the immunosuppressive regimen in heart transplantation. J Heart Lung Transplant 2004;23:S207–13.
20. Stratta RJ. Review of immunosuppressive usage in pancreas transplantation. Clin Transplant 1999;13:1–12.